Edwards Lifesciences Corporation (EW) Operating margin 2016–2025
Edwards Lifesciences Corporation (EW) operating margin by fiscal year — reported operating income divided by reported revenue.
20.8%FY2025 · since FY2016: 25.3% → 20.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 20.8% | -4.5 pp |
| FY2024 | 25.3% | -0.8 pp |
| FY2023 | 26.1% | -7.4 pp |
| FY2022 | 33.6% | +1.3 pp |
| FY2021 | 32.3% | +11.8 pp |
| FY2020 | 20.5% | -5.9 pp |
| FY2019 | 26.4% | +6.3 pp |
| FY2018 | 20.1% | -11.6 pp |
| FY2017 | 31.7% | +6.4 pp |
| FY2016 | 25.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice